3 hours Bank of America Reaffirms “Buy” Rating for CG Oncology (NASDAQ:CGON) MarketBeat
Bank of America reaffirmed a “buy” rating and set a $65.00 price target on shares of CG Oncology in a research note on Tuesday.
Bank of America (BAC) · Nasdaq 100 · Science